Taysha Gene Therapies, Inc.TSHANASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank17
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-93.09M
↓ 35% vs avg
Percentile
P17
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
$-69.05M
Historical baseline
PeriodValueYoY Change
2025$-93.09M-14.6%
2024$-81.22M-11.2%
2023$-73.02M+17.4%
2022$-88.39M+24.5%
2021$-117.04M-280.9%
2020$-30.73M-22862.2%
2019$135000.00-